Just In
- 6 hrs ago Backless Dress: 7 Tips For Choosing Perfect Bra For Backless Outfits And Turn Heads Wherever You Go
- 15 hrs ago Summer Style: 6 Must-Try Colors To Stay Fashionably Cool Like B-Town Divas!
- 17 hrs ago Belgian Man Cleared Of Drunk Driving Because His Body Produces Alcohol Due To A Rare Condition
- 18 hrs ago Amitabh Bachchan's Youthful Avatar In Kalki 2898 AD Is Impressive, Check Actors Who Sported Digital De-Aging!
Don't Miss
- Education JEE Main Result 2024 Out, Telangana's 15 Toppers Shine, Check Statewise List of 56 Candidates with Perfect 100
- Sports Who Won Yesterday's IPL Match 40? DC vs GT, IPL 2024 on April 24: Delhi Capitals Clinch High-Scoring Thriller At Kotla
- News Mangalsutra Row: Did Indira Gandhi Donate Gold During The 1962 War? The Facts Behind Priyanka's Claim
- Movies Kota Factory 3 OTT Release Date, Platform: When Will Jitendra Kumar's Web Series Premiere On Netflix?
- Travel Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
- Finance DCB Bank Q4 Results: PAT Grew 9% To Rs 156 Cr, NII Jumps 4.5%; Dividend Declared
- Technology OPPO Find X7 Ultra Camera Deep-Dive: Pushing the Boundaries of Photography on a Smartphone
- Automobiles Aston Martin Vantage Launched In India At Rs 3.99 Crore
Some Short-Term Benefits Of Additional Booster Dose Of mRNA Vaccine In Health Workers: WHO
The WHO has said that there is a benefit of administering an additional booster dose of the mRNA COVID-19 vaccine for the highest risk groups, health workers, those over 60 years of age or with immunocompromising conditions.
As a general principle, an interval of 4-6 months since completion of the primary series of the vaccine could be considered for a first booster, especially in the context of Omicron, said the World Health Organisation, with the support of the Strategic Advisory Group of Experts (SAGE) on immunisation and its COVID-19 Vaccines Working Group.
The WHO said that in considering additional booster doses, the two main scenarios to assess are the use of additional booster doses in those who are not able to mount and sustain adequate immune responses and considerations for additional booster doses to be administered in order to protect high-risk populations and health workers to maintain the health system during periodic waves of disease surges.
It said that available data for WHO EUL COVID-19 vaccine products suggest that vaccine effectiveness and immunogenicity are lower in immunocompromised persons (ICPs), compared to persons without immunocompromising conditions.
"An additional dose included in an extended primary series enhances immune responses in some ICPs. Given the significant risk of severe COVID-19 for ICPs, if infected, WHO has already issued a recommendation for an extended primary series (i.e. third dose) as well as a booster dose (i.e. fourth dose) for ICPs, for all COVID-19 vaccines," it said.
The WHO noted that additional booster doses beyond the first booster dose are currently being offered by some countries, adding that data on additional booster doses as of May 2022 only exists for the mRNA vaccines, and not for other vaccine platforms.
The WHO cited seven studies, conducted during a time when Omicron was the predominant circulating strain globally, that evaluated the relative effectiveness of a fourth dose four months after a third dose of mRNA vaccine compared to those who received three doses.
"Taken together, these studies show some short-term benefit of an additional booster dose of mRNA vaccine in health workers, those over 60 years of age or with immunocompromising conditions," the WHO said.
It said that data to support an additional dose for healthy younger populations is limited; preliminary data suggests that in younger people, the benefit is minimal.
"The limited available data suggest that for highest risk groups, there is a benefit that supports the administration of an additional booster dose," the WHO said, adding that in those most at risk for severe disease or death (adults over the age of 60 years, or those who are not able to mount a full immune response), the additional benefit of an additional booster dose of mRNA vaccine might be "warranted".
It said while seasonality is not yet fully established for SARS-CoV-2, evidence from the past two years supports the notion of more substantial transmission during the winter season.
"Therefore, for countries with either a Northern or Southern Hemisphere winter season, plans for a catch-up to improve primary series coverage and boosting for those at highest risk, campaigns should take seasonality into account," the WHO added.
- disorders cureIndia May See A Covid Surge In January, Next 40 Days Crucial; Here Is How To Protect Yourself From COVID-19
- disorders cureCOVID Can Trigger Parkinson's Disease: Study
- disorders cureCommon COVID Symptoms In Fully Vaccinated Individuals: What You Should Know
- wellnessMild COVID Linked To Life-Threatening Blood Clots, Increased Risk Of Cardiovascular Disease; Study
- wellnessCOVID-19 Variants In India: New COVID Variant May Pose Threat To Elderly People
- basicsCovid-19 Linked To Early Onset Of Periods: What You Need To Know
- wellnessCOVID XBB Variants Of Omicron In India: What You Should Know
- disorders cureNew Omicron Subvariant BQ.1 Detected In Maharashtra: What You Should Know
- disorders cureOmicron BF.7 In India, Risk Of Fresh Wave During Diwali: What You Should Know
- womenPriyanka Chopra Speaks On Climate Change, COVID, Poverty At The UN Sustainable Development Goals 2022 Moment
- wellnessCoronavirus Residues Might Be Causing Long COVID: New Study
- art cultureRenowned Spanish Author Javier Marias Passes Away Due To Lung Infection Post COVID-19